Description

N,n-Diethyl-2-[(5-Methyl-5H-Pyridazino[3,4-B][1,4] Benzoxazin-3-Yl)Oxy]Ethanamine Dihydrochloride is a high-purity, complex heterocyclic compound primarily utilized as a critical pharmaceutical intermediate. Its value lies in its role as a sophisticated building block for the synthesis of novel active pharmaceutical ingredients (APIs), particularly in central nervous system (CNS) and oncology research. This product is essential for pharmaceutical R&D laboratories, fine chemical manufacturers, and contract research organizations (CROs) engaged in developing new therapeutic agents.

Application

• Pharmaceutical Intermediate: Key building block for the synthesis of novel drug candidates, especially in CNS and oncology research.
• Research & Development: Used in medicinal chemistry for structure-activity relationship (SAR) studies and lead optimization.
• Fine Chemical Synthesis: Serves as a precursor for creating more complex, high-value heterocyclic compounds.
• Contract Manufacturing: Supplied to CROs and CDMOs for custom synthesis and process development projects.
• Academic Research: Utilized in university and institutional labs for pharmacological and biochemical studies.
• Reference Standard: Can be supplied as a high-purity standard for analytical method development and validation.

Basic Information

Product Name	N,n-Diethyl-2-[(5-Methyl-5H-Pyridazino[3,4-B][1,4] Benzoxazin-3-Yl)Oxy]Ethanamine Dihydrochloride
CAS No.	55931-84-5
Molecular Formula	C₁₉H₂₅Cl₂N₃O₂
Molecular Weight	398.33 g/mol
Synonyms	N,N-Diethyl-2-[(5-methyl-5H-pyridazino[3,4-b][1,4]benzoxazin-3-yl)oxy]ethanamine dihydrochloride; 2-[(5-Methyl-5H-pyridazino[3,4-b][1,4]benzoxazin-3-yl)oxy]-N,N-diethylethanamine dihydrochloride; Ethanamine, N,N-diethyl-2-[(5-methyl-5H-pyridazino[3,4-b][1,4]benzoxazin-3-yl)oxy]-, dihydrochloride; 55931-84-5; 5-Methyl-3-(2-diethylaminoethoxy)pyridazino[3,4-b][1,4]benzoxazine dihydrochloride
EINECS	Contact for details

Quality Control

Our N,n-Diethyl-2-[(5-Methyl-5H-Pyridazino[3,4-B][1,4] Benzoxazin-3-Yl)Oxy]Ethanamine Dihydrochloride is manufactured under strict quality management systems. Each batch undergoes rigorous analytical testing, including HPLC for purity and identity confirmation, to ensure it meets the high standards required for pharmaceutical R&D. A comprehensive Certificate of Analysis (COA) detailing purity, impurities, and physical characteristics is provided with every shipment to guarantee traceability and batch-to-batch consistency.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (15-25°C). Due to its hygroscopic (moisture-sensitive) nature, the container must be kept tightly sealed in a dry environment to prevent degradation. For long-term storage, consider desiccants or inert atmosphere.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to reference spectrum
Identification (HPLC)	Retention time matches reference standard
Assay (HPLC)	≥ 98.0%
Water Content (KF)	≤ 1.0%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 20 ppm
Related Substances (HPLC)	Total impurities ≤ 2.0%; Any single impurity ≤ 0.5%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.